Vimarsana
Biggest News Aggregation in the World

Page 6 - B Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Cell Today - Breaking & Trending Today

DAVIDsTEA delivers flavor-and-function-forward teas - Vimarsana News

DAVIDsTEA delivers flavor-and-function-forward teas

DAVIDsTEA is growing its loose tea portfolio with more adaptogen-forward blends that promote a wide range of health attributes like relaxation, sleep, energy and more.

Study finds that germline-encoded specificities cannot always predict the trajectory of B-cell responses - Vimarsana News

Study finds that germline-encoded specificities cannot always predict the trajectory of B-cell responses

Researchers used computational simulations and experiments to investigate how genetic variations encoded in the germline impact B-cell responses.

A comprehensive online resource allows for the exploration of interactions between mutational signatures and topographical features across human cancer - Vimarsana News

A comprehensive online resource allows for the exploration of interactions between mutational signatures and topographical features across human cancer

An online resource for studying the relationship between mutational signatures and topographical characteristics across human cancer.

Artificial intelligence and polyclonal antibody sequencing - Vimarsana News

Artificial intelligence and polyclonal antibody sequencing

In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.

New method to assess the status of immune responses to specific antigens in detail - Vimarsana News

New method to assess the status of immune responses to specific antigens in detail

A new method to assess the status of immune responses to specific antigens in detail by analysis using the B cell receptor (BCR) repertoire has been developed by a research group, consisting of Assistant Professor Yohei Funakoshi, Associate Professor Kimikazu Yakushijin, Professor Hironobu Minami (Kobe University Graduate School of Medicine), Associate Professor Goh Ohji (Kobe University Hospital), and Researcher Takaji Matsutani (Repertoire Genesis Inc.).